InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Koschak William, Chief Financial Officer. Director active across 2 companies, notably Calyxt, Inc.. Aggregated, 12 disclosures have been logged. Split: 2 buys · 0 sell. Total volume traded: €110k. Activity tracked since 19 August 2021. The latest transaction was filed on 31 May 2023 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations12 total
6,333 shares0Common StockSEC:0001615594-23-000045:0
10,945 shares0Common StockSEC:0001615594-23-000025:0
11,967 shares@ US$0.343.0% of flowCommon StockSEC:0001615594-23-000024:0
2,483 shares@ US$0.310.6% of flowCommon StockSEC:0001615594-23-000018:0
11,967 shares@ US$0.43013.8% of flowCommon StockSEC:0001615594-23-000013:0
473,900 shares0Common StockSEC:0001615594-23-000011:0
23,751 shares0Common StockSEC:0001615594-23-000007:0
42,570 shares@ US$0.14754.6% of flowCommon StockSEC:0001615594-23-000002:0
100,000 shares0Common StockSEC:0001615594-22-000021:0
2,605 shares@ US$1.05182.2% of flowCommon StockSEC:0001615594-22-000013:0
20,000 shares@ US$3.205648.9% of flowCommon StockSEC:0001615594-21-000095:0
Ideal exit: 16 May 2022 (T+270)
20,000 shares@ US$3.205643.1% of flowCommon StockSEC:0001615594-21-000095
Ideal exit: 16 May 2022 (T+270)
12 of 12 declarations
About Koschak William
William Koschak is the Chief Financial Officer of Calyxt, Inc., a biotechnology company specializing in genetic modification of crops. As CFO, he oversees financial operations and contributes to the company's growth strategy. William Koschak plays a crucial role in managing financial resources and optimizing Calyxt's economic performance.
